In the article (links provided) "Pay-For-Performance is No Miracle Cure," by Pauly; the author make an argument that tying the price of a drug to its effectiveness is a form of price discrimination. (ii) Pauly concludes that it is highly unlikely that consumers will be better off as a group if monopolistic pharmaceutical companies practice discriminatory pricing. Analyze this claim using economic intuition. https://www.usnews.com/opinion/blogs/policy-dose/2015/06/05/drug-price-discrimination-isnt-a-cure-all-for-costly-meds?context=amp